medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2021, Number 1

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2021; 37 (1)

Frequency of hemoglobinopathies among pregnant women from the sickle cell anemia program in Cuba

Valdés FY, Pérez RJ, Concepción ÁA, Acosta ST, Suárez BB, Llacer RD, Correa JSB

Language: Spanish
References: 17
Page: 1-16
PDF size: 439.06 Kb.


ABSTRACT

Introduction: Hemoglobinopathies are hereditary monogenic errors characterized by defects in the hemoglobin molecule. In Cuba, prenatal detection of hemoglobinopathies is performed by hemoglobin electrophoresis to identify high-risk couples. The program offers genetic counseling, prenatal molecular diagnosis and selective pregnancy termination in case of affected fetuses at the request of couples.
Objective: Determine the frequency of hemoglobinopathies among pregnant women living in Cuba.
Methods: A descriptive cross-sectional retrospective study was conducted to determine the frequency of hemoglobinopathies in 1 342 917 pregnant women recruited in the period 2009-2019. Screening was based on the diagnostic method of hemoglobin electrophoresis in alkaline pH agarose gels. Confirmation was performed with hemoglobin electrophoresis in acid pH agarose gel. Both methods used HYDRASYS technology.
Results: Overall frequency of pregnant women with hemoglobinopathies was 3.5%. Hemoglobinopathies were detected in 47 465 women: 38 698 with variant S heterozygote, 8 706 with variants of hemoglobin C y 158 with other variants. 44 283 husbands with hemoglobinopathies and 3 099 high-risk couples were detected, and 2 689 prenatal molecular diagnostic tests were conducted. A total 522 affected fetuses were confirmed, and 382 couples requested pregnancy termination. The subprogram achieved 99.24% coverage in the country.
Conclusion: The high frequency of hemoglobinopathies in Cuba justifies the importance of continuing the carrier detection subprogram to prevent the emergence of severe forms of the disease.


REFERENCES

  1. Kato G, Piel F, Reid C, Gaston M, Ohene K, Krishnamurti L, et al. Sickle cell disease. Nat Rev Dis Primers. 2018;15(4):18010. DOI: https://10.1038/nrdp.2018.10

  2. Piel F, Steinberg M, Rees D. Sickle Cell Disease. N Engl J Med. 20 Apr 2017; 376(16):1561-73. DOI: https://10.1056/NEJMra1510865

  3. Degandt S, Coens R, Cauwelier B, Devos H, Langlois M, Emmerechts J. Evaluation of four hemoglobin separation analyzers for hemoglobinopathy diagnosis. J Clin Lab Anal 2018;32(1):e2224. DOI: https://10.1002/jcla.22224

  4. Iyer S, Sakhare S, Sengupta C, Velumani A. Hemoglobinopathy in India. Clin Chim Acta. 2015;444:229-33.

  5. Weatherall D, Clegg J. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704-12.

  6. Martín R, Beltrán B, García C, Fuentes S. Sickle cell anemia and hemoglobin SC disease incidente rates in Havana City, Cuba, from 1995 to 2004. Rev Cubana Gen Com. 2007;1(1):45-50.

  7. Martin Ruiz MR, Lemus Valdés MT, Marcheco Teruel B. El programa cubano de prevención de Anemia Falciforme. Resultados del periodo 1990 - 2005. Rev Cubana Genet Comunit. 2008 [acceso 20/01/2020]; 2(2). Disponible en: Disponible en: http://bvs.sld.cu/revistas/rcgc/v2n2/rcgc10208.htm

  8. García O, Chacín M, Bravo M, Gómez G, Montilla S, Merzónc R, et al. Diagnóstico de hemoglobinopatías a partir de sangre del talón de recién nacidos en diferentes centros hospitalarios de Venezuela An Pediatr (Barc). 2009;71(4):314-8 DOI: https://10.1016/j.anpedi.2009.07.005

  9. Reis F, Branco R, Conceição A, Trajano L, Vieira J, Ferreira P, et al. Incidence of variant hemoglobins in newborns attended by a public health laboratory. Einstein (Sao Paulo). 7 Jun 2018;16(2):eAO4150. DOI: https://10.1590/S1679-45082018AO4150

  10. L, GómezR, Algora H, Noa M, Arcas E, Noche G, et al. Resultados del Programa de prevención de hemoglobinopatías SS y SC en el periodo 1987-2007 en la provincia Villa Clara, Cuba. Rev Cub Gen 2010;4(1):37-41.

  11. Valdes Y, Pérez J, Fuentes I, Gámez G, Concepción A, Suárez B. Resultados del Programa de Prevención de Anemia Falciforme en el Centro Na-cional de Genética Médica de Cuba (2008-2014). Rev Cubana Genet Comunit. 2016;10(1):36-40.

  12. Leyva O, Martínez A, Calvo M, Martín N, Rubinos A. Frecuencia de portadoras de hemoglobina S y C en gestantes de la provincia Guantánamo, 2005-2009. Rev Cubana Genet Comunit. 2010;4(3):54-6.

  13. González R, Maza M, Oliva Y, Menéndez R. Resultados del programa de prevención de hemoglobinopatías SS y SC Rev Ciencias Médic. 2013;17(4):44-53.

  14. Marcheco B, Fuentes E, Marín L, Gómez E. Cuba: Estudio de la historia del mestizaje y de las bases genéticas de la pigmentación de la piel utilizando marcadores autosómicos y uniparentales. Anales de la Academia de Ciencias de Cuba. 2015;5(3): [Internet]. 2016 [acceso 20/01/2020] Disponible en: Disponible en: http://www.revistaccuba.sld.cu/index.php/revacc/article/view/298

  15. Bouchán P, Coeto G, Rosenfeld F, Trueba R, Baptista H, Rivera M, et al. Identificación molecular de la hemoglobina D Punjab en dos familias. Rev Med Inst Mex Seguro Soc. 2016;54(6):793-800.

  16. Hazan E, Navarro J, Marquez M, Castillo J. Hemoglobina O arabia y hemoblobina Hofu: Reporte de tres familias en el Perú. Rev Med Hered. 2013;6(1):1-7. DOI: https://10.20453/rmh.v6i1.473

  17. Martín R, Beltrán B, García C, Fuentes S. Eficiencia de las acciones preventivas prenatales en relación con niños nacidos con anemia falciforme. Rev Cubana Gen Com. 2007;1(2):35-41.




2020     |     www.medigraphic.com